Neurodiagnostics Market Provides In-Depth Analysis of the Industry, With Current Trends and Future Estimations to Elucidate The Investment Pockets

Market Highlights

According to MRFR analysis, the Global Neurodiagnostics Market is expected to register a CAGR of 6.88% from 2019 to 2025 and held a value of USD 4,848.48 Million in 2018.

Neurodiagnostic tests which are also known as neurodiagnostics. records and monitors electrical activities of patient’s peripheral nerves, spinal cord, and brain. These tests help physicians to confirm or rule out a neurological disorder or other medical condition. The growth of the global neurodiagnostics market is boosted by factors such as rising number of strategic initiatives by key players such as mergers, joint ventures, acquisitions, partnerships, coupled with the advancements in technology across the globe. Furthermore, many non-profit organizations in various countries are working towards creating awareness regarding neurological diseases. For instance, the World Federation of Neurology (WFN), founded in July 2016, is a membership organization focused on raising awareness about the age and neurological conditions and diseases associated with age.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/8762

Market players such as GE Healthcare, Siemens Healthineers, Philips Healthcare, and Hitachi, Ltd., currently dominate the global neurodiagnostics market. The key players are involved in product launches and agreements to strengthen their market positions. For instance, in December 2019, GE Healthcare (US), signed USD 100 million technology partnership agreement with AFFIDEA (Ireland). GE Healthcare will install 200+ new equipment in Affidea’s network of centers across Europe. The deal includes the provision of 60 new MRIs, 50 ultrasound devices, 40 CT scanners and 30 X-rays machines in the next 3 years. It also includes a six-year service contract.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas held maximum share in the base year 2018, owing to the high incidence rates of neurological disorders in countries such as US. According to the American Neurological Association, as of 2016, mealy 100 million Americans were affected by at least one of the neurological diseases. The neurodiagnostics market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European neurodiagnostics market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

Segmentation

The Global Neurodiagnostics Market has been segmented based on Product, Condition, and End User.

The market, based on product type, has been divided into diagnostic imaging systems, clinical diagnostic instruments, and reagents & consumables. The diagnostic imaging systems segment held a major share in 2018 owing to the rising number of diagnostic laboratories an imaging centers in the developing as well as developed countries. The reagents & consumables was the fastest-growing segment in 2018 due to high consumption in various routine techniques. The market, based on diagnostic imaging systems, has been further segment is segmented as, MRI systems, EEG systems, CT scanners, PET scanners, EMG devices, ultrasound imaging systems, MEG devices, angiography systems, and others. The market, based on clinical diagnostic instruments has been further bifurcated into PCR instruments, NGS instruments, sanger sequencers, and others. The market, based on reagents & consumables has been further segmented into media & sera, antibodies, buffers, solvents, enzymes, proteins, & peptides, probes, and other.

Key Players

Some of the key players in the global neurodiagnostic market are GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Thermo Fisher Scientific, Inc. (US), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), and QIAGEN N.V. (Netherlands).

Browse Full Report Details @

https://www.marketresearchfuture.com/reports/neurodiagnostics-market-8762

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com